Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Fil Manuguid"'
Autor:
Alexander Slowley, Kelesitse Phiri, Jasjit K. Multani, Vicky Casey, Sheila Mpima, Marie Yasuda, Chi‐Chang Chen, Fil Manuguid, Jessica Chao, Amine Aziez, Kelly F. Bell, Alexander Stojadinovic
Publikováno v:
Thoracic Cancer, Vol 14, Iss 28, Pp 2846-2858 (2023)
Abstract Background Real‐world evidence is increasingly used to guide treatment and regulatory decisions for non‐small cell lung cancer (NSCLC). Real‐world treatment patterns and clinical outcomes among patients with advanced/metastatic NSCLC i
Externí odkaz:
https://doaj.org/article/2bafcf605a8c49ab901542b701ab65ea
Autor:
Nashita Patel, Shibani Pokras, Jane Ferma, Vicky Casey, Fil Manuguid, Ken Culver, Sebastian Bauer
Publikováno v:
Future Oncology.
Aim: Describing the treatment patterns, outcomes by line of treatment (LOT), and healthcare resource utilization (HCRU) in patients with metastatic synovial sarcoma (mSS). Patients & methods: In this descriptive, non-interventional, retrospective coh
Autor:
Sari Heitner Enschede, Fil Manuguid, Carolina Ricarte, María López Suárez, Kriti Jindal, Sheila Mpima
Publikováno v:
Blood. 140:13178-13179
Autor:
Patrick Cheung, Julien Taieb, Victoria Banks, George Kafatos, Kimberly Lowe, Fil Manuguid, Peter Burdon, Caroline Anger, Joannes H. J. M. van Krieken, David Neasham
Publikováno v:
Future Oncology. 17:1483-1494
Background: The literature on biomarker testing for metastatic colorectal cancer (mCRC) in Europe is scarce. This study aimed to estimate the percentage of mCRC patients from five European countries tested for biomarkers over time. Materials & method
Publikováno v:
Future oncology (London, England). 17(21)
Aim: Assess treatment patterns and healthcare resource utilization (HRU) in patients with treatment-naive (TN) or relapsed/refractory (R/R) acute myeloid leukemia (AML) in Europe. Patients & methods: Cross-sectional, retrospective, web-based survey o
Publikováno v:
Annals of Oncology. 32:S311
Autor:
Thomas Moehler, Fil Manuguid, Sari H. Enschede, Magdalena Ruiz, Luana Margotto Soares, Vicky Casey, Kriti Jindal
Publikováno v:
Blood. 136:28-28
Introduction: Treatment options for acute myeloid leukaemia (AML) patients have increased in recent years as several novel targeted medications for AML patients have been introduced. The aim of this study was to identify the integration of novel trea
Publikováno v:
Journal of Clinical Oncology. 38:e19327-e19327
e19327 Background: Micro-Satellite Instability (MSI) or DNA Mismatch Repair (MMR) is an established prognostic test associated with response to chemotherapies in Lynch Syndrome, colorectal cancer and other indications. Recently, MSI/MMR status has be
Publikováno v:
Annals of Oncology. 29:viii571
Publikováno v:
Journal of Clinical Oncology. 36:e21085-e21085
e21085Background: Between 25% and 40% of NSCLC patients develop CNS metastases, a high unmet medical need with median survivals of 3–14 months. Using a large oncology real-world patient database, w...